Breakthrough HIV Drug Is Out Of Reach For Many Who Need It Most
|
Lenacapavir, almost 100% effective at preventing HIV,
is priced by Gilead at $28200 and inaccessible to many in low-income
countries plagued by ... |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.